ATE550033T1 - Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoff - Google Patents
Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoffInfo
- Publication number
- ATE550033T1 ATE550033T1 AT06253982T AT06253982T ATE550033T1 AT E550033 T1 ATE550033 T1 AT E550033T1 AT 06253982 T AT06253982 T AT 06253982T AT 06253982 T AT06253982 T AT 06253982T AT E550033 T1 ATE550033 T1 AT E550033T1
- Authority
- AT
- Austria
- Prior art keywords
- pqgab
- prrsv
- kdel
- vaccine
- pork
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06253982A EP1882478B1 (de) | 2006-07-29 | 2006-07-29 | Fusionsproteine des reproduktiven und respiratorischen Syndrom Virus aus dem Schwein als PRRS Impfstoff |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE550033T1 true ATE550033T1 (de) | 2012-04-15 |
Family
ID=37517616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06253982T ATE550033T1 (de) | 2006-07-29 | 2006-07-29 | Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoff |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1882478B1 (de) |
AT (1) | ATE550033T1 (de) |
ES (1) | ES2384524T3 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI417385B (zh) * | 2010-05-04 | 2013-12-01 | Univ Nat Taiwan | 以植物生產之豬生殖與呼吸道綜合症口服疫苗及其用途 |
US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
US10010602B2 (en) * | 2015-06-01 | 2018-07-03 | Reber Genetics Co., Ltd. | Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases |
SG11202009925PA (en) | 2018-03-08 | 2020-11-27 | Applied Molecular Transport Inc | Toxin-derived delivery constructs for oral delivery |
TW202031297A (zh) | 2018-11-07 | 2020-09-01 | 美商應用分子運輸公司 | 用於經口遞送異種負載之衍生自cholix的載體 |
CN113046329B (zh) * | 2020-11-10 | 2024-01-30 | 山东省滨州畜牧兽医研究院 | 猪繁殖与呼吸障碍综合征病毒嵌合重组的PRRSV DIVA疫苗株cDY56 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7335361B2 (en) * | 2003-06-09 | 2008-02-26 | Animal Technology Institute Taiwan | Fusion antigen used as vaccine |
-
2006
- 2006-07-29 ES ES06253982T patent/ES2384524T3/es active Active
- 2006-07-29 EP EP06253982A patent/EP1882478B1/de active Active
- 2006-07-29 AT AT06253982T patent/ATE550033T1/de active
Also Published As
Publication number | Publication date |
---|---|
ES2384524T3 (es) | 2012-07-06 |
EP1882478A1 (de) | 2008-01-30 |
EP1882478B1 (de) | 2012-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2572555A1 (en) | Fusion protein of porcine reproductive and respiratory syndrome virus as prrs vaccine | |
ATE550033T1 (de) | Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoff | |
WO2010074575A3 (en) | Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. | |
RU2015122368A (ru) | Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа | |
JP2009537143A5 (de) | ||
WO2002012281A3 (en) | Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen | |
ATE365746T1 (de) | Prrsv-antigene, die auf peptidsequenzen des prrs- virus basieren, für die verwendung als impfstoff und für diagnostische tests | |
Maeda et al. | Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein | |
MX358912B (es) | Vacuna de marcadores basados en péptidos sintéticos y sistema de diagnóstico para el control efectivo del síndrome reproductivo y respiratorio porcino (prrs). | |
WO2005081716A3 (en) | DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) | |
JP2011500035A5 (de) | ||
EP1794329A4 (de) | Isolate des das reproduktions- und atemwegssyndrom verursachenden schweinevirus und ihre verwendung | |
MX2009011638A (es) | Composiciones basadas en gp5 de prrsv y metodos. | |
CA2516511C (en) | Fusion protein for inhibiting cervical cancer | |
WO2001045639A3 (en) | Methods for protecting against lethal infection with bacillus anthracis | |
Zhu et al. | A bacteriophage-based, highly efficacious, needle-and adjuvant-free, mucosal COVID-19 vaccine | |
RU2007115411A (ru) | Пептиды hsp60 и их apl-производные и фармацевтические композиции | |
ATE527237T1 (de) | Modifizierter mscl-proteinkanal | |
Cacciottolo et al. | Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants | |
Greene et al. | LT-IIb (T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity | |
MX2011004176A (es) | Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo. | |
DK1796713T3 (da) | Anvendelse af GILZ-protein til modulation af et antigenspecifikt immunrespons | |
WO2006007366A3 (en) | SKIN IMMUNIZATION USING LT-STa FUSION PROTEINS | |
WO2007098717A3 (es) | Antígenos vacunales quiméricos contra el virus de la peste porcina clásica | |
AR071635A1 (es) | Variantes de crig (receptor asociado a macrofagos) que tienen afinidad de union aumentada a c3b, con union selectiva sobre c3 (ambas proteinas del complemento). |